AMCR vs TMO · P/E 18, rev $23.51B vs P/E 24, rev $23.00B
Amcor PLC (AMCR) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the AMCR and TMO stock pages for the full models.
Not investment advice.